Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients

Abstract RUNX1 mutations are frequently detected in various myeloid neoplasms and implicate unfavourable clinical outcomes in patients with myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). On the other hand, high expression of RUNX1 is also correlated with poor prognosis in AML pati...

Full description

Bibliographic Details
Main Authors: Yu‐Hung Wang, Chi‐Yuan Yao, Chien‐Chin Lin, Chi‐Ling Chen, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:eJHaem
Subjects:
leukaemic stem cells signature
myelodysplastic syndrome
prognostication
RUNX1 expression
survival
Online Access:https://doi.org/10.1002/jha2.547

Internet

https://doi.org/10.1002/jha2.547

Similar Items